Dimenhydrinate

Manufacturer
Acme United Corporation
Effective date
2020-11-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:33:49

Label at a glance#

ProductDimenhydrinate
Active ingredientDIMENHYDRINATE
Label structure10 sections

Indications and uses

for prevention and treatment of nausea, vomiting or dizziness associated with motion sickness

Dosage and administration

To prevemt motion sickness the first dose should be taken ½ to 1 hour before starting activity. To prevent or treat motion sickness: Adults and Children (12 years and older) take 1-2 tablets every 4-6 hours, not more than 8 tablets in 24 hours, or as directed by doctor. Children 6 to under 12 years give 1 tablet every 6-8 hours, not more than 3 tablets in 24 hours or as directed by doctor. Children 2 to under 6 ye...

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient (in each tablet)

Dimenhydrinate 50 mg

OTC - PURPOSE SECTION

Purpose

Antiemetic

Uses

INDICATIONS & USAGE SECTION

for prevention and treatment of nausea, vomiting or dizziness associated with motion sickness

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use in children under 2 years of age unless directed by a doctor

OTC - ASK DOCTOR SECTION

Ask doctor before use if you have

  • breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • trouble urinating due to an enlarged prostate gland.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask doctor or pharmacist before use if you are taking sedatives or tranquilizers.

OTC - WHEN USING SECTION

When using this product

  • marked drowsiness may occir
  • avoid alcoholic drinks
  • alcohol, sedatives and traquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a helath professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact Poison Control Center (800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

To prevemt motion sickness the first dose should be taken ½ to 1 hour before starting activity.

To prevent or treat motion sickness:

Adults and Children (12 years and older)take 1-2 tablets every 4-6 hours, not more than 8 tablets in 24 hours, or as directed by doctor.
Children 6 to under 12 yearsgive 1 tablet every 6-8 hours, not more than 3 tablets in 24 hours or as directed by doctor.
Children 2 to under 6 yearsgive ¼ to ½ tablet every 6-8 hours, not more than 1½ tablets in 24 hours or as directed by a doctor

Other information

OTHER SAFETY INFORMATION

  • each tablet contains calcium 29 mg
  • store at room temperature
  • do not use if packet is open or torn

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose

Questions?

OTC - QUESTIONS SECTION

1-800-835-2263

SPL UNCLASSIFIED SECTION

Retain carton for complete product information

Manufactured for:

Acme United Corporation

55 Walls Dr, Fairfield, CT 06824

www.FirstAidOnly.com

Made in the USA

©2018 Acme United Corporation

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Physician Care®

Motion Sickness

Dimenhydrinate/ Antiemetic

Nausea, Vomiting and Dizziness Relief

Tamper-Evident Packets of 2 Tablets

Do not use if packet is open or torn.

Dimenhydrinate 50mg

100 Tablets (50 Packets, 2 Tablets each)

1006-updated-label1006-updated-label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
198603dimenhyDRINATE 50 MG Oral TabletPSN2
198603dimenhydrinate 50 MG Oral TabletSCD2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
865c72dd-0d94-daac-f728-ddd4ded2a79eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0924-1007-012023-01-30C16284748780-1f386c649-b430-0266-e053-dadaa90a7c1a1006-Acme
0924-1007-022023-01-30C16284748780-1f386c649-b430-0266-e053-dadaa90a7c1a1006-Acme
0924-1007-032023-01-30C16284748780-1f386c649-b430-0266-e053-dadaa90a7c1a1006-Acme

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0924-1007-01Dimenhydrinate50 in 1 CARTONTABLET502
0924-1007-01Dimenhydrinate2 in 1 PACKETTABLET22
0924-1007-02Dimenhydrinate6 in 1 BAGTABLET62
0924-1007-02Dimenhydrinate2 in 1 PACKETTABLET22
0924-1007-03Dimenhydrinate100 in 1 BOTTLETABLET1002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0924-1007DIMENHYDRINATE TABLET [ACME UNITED CORPORATION]2Legacy NDC, 5 package rows20201118_7b32c52a-f2b0-4acc-e053-2a91aa0a5bcc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0924-10070924-1007-02, 0924-1007-01, 0924-1007-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b44fec56-48e0-1d87-e053-2a95a90a10c87b32c52a-f2b0-4acc-e053-2a91aa0a5bcc2020-11-17WarningsExact identifier
spl id: b44fec56-48e0-1d87-e053-2a95a90a10c8
spl set id: 7b32c52a-f2b0-4acc-e053-2a91aa0a5bcc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.